Top Movers

Company Announcements

Stabilisation Notice

By LSE RNS

RNS Number : 4542K
Citigroup Global Markets Limited
13 December 2018
 

 

13 December 2018

Not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States of America, Australia, Japan, Singapore, the United Arab Emirates, the Kingdom of Saudi Arabia or any jurisdiction in which such distribution would be unlawful.

 

Nova Ljubljanska banka d.d.

 

Post-stabilisation notice and exercise of the over-allotment option

 

Full exercise of the over-allotment option

Deutsche Bank AG, London Branch, J.P. Morgan Securities plc, Citigroup Global Markets Limited and WOOD & Company Financial Services, a.s., acting as the managers in connection with the initial public offering (the "Offer") of shares in Nova Ljubljanska banka d.d., Ljubljana (the "Company"), have today given notice to exercise the over-allotment option granted by Slovenski državni holding d.d. in respect of 1,181,819 ordinary shares (equivalent to 5,909,095 GDRs) (in the form of ordinary shares and/or GDRs) of the Company (the "Over-allotment Shares") at the Offer price of EUR 10.30 per Over-allotment GDR (the "Over-allotment Option"). Settlement of the Over-allotment Option will take place on 18 December 2018.

 

Including the exercise of the Over-allotment Option, the final total size of the Offer was 54,998,830 GDRs and 2,000,234 ordinary shares, combined representing 65 per cent of the Company currently.

 

Stabilisation notice

 

Further to its announcement on 13 December 2018, Citigroup Global Markets Limited (Contact: Syndicate Desk +44 20 7986 9000), in its capacity as stabilisation manager, hereby gives notice that it did not undertake stabilisation (within the meaning of Article 3.2(d) of Market Abuse Regulation (EU/596/2014)) in relation to the offer of the following securities and is terminating the stabilisation period:

The securities:

Issuer:

Nova Ljubljanska Banka d.d.

Securities:

Global Depository Receipts (GDRs)

5 GDRs represent an interest in 1 ordinary share

ISIN:

Regulation S GDR ISIN: US66980N2036

Rule 144A GDR ISIN: US66980N1046

Offering size:

50,567,010 GDRs, excluding the over-allotment option

(The offering also included an additional 1,704,779 ordinary shares listed on the Ljubljana Stock Exchange)

Market:

London Stock Exchange

Ticker:

NLB LI

Maximum size of over-allotment facility

1,181,819 ordinary shares (equivalent to 5,909,095 GDRs) (in the form of ordinary shares and/or GDRs)

Description:

Public Offering of Ordinary Shares and GDRs

Offer price:

EUR 10.30 per GDR and EUR 51.50 per Share

Associated securities:

The underlying ordinary shares which are listed on Ljubljana Stock Exchange

Stabilisation:

Stabilising Manager:

Citigroup Global Markets Limited, Citigroup Centre, Canada Square, Canary Wharf, London E14 5LB, United Kingdom

Stabilisation period:

From 14 November 2018 to 13 December 2018

Trade Date

None

Lowest price paid (pence)

None

Highest price paid (pence)

None

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is addressed to and directed at persons in Member States of the European Economic Area ("Member States") who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC, as amended) and related implementation measures ("Qualified Investors"). In addition, in the United Kingdom, this announcement is being distributed only to, and is directed only at Qualified Investors who are, (i) persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") and/or (ii) who are high net worth bodies corporate, unincorporated associations and partnerships or the trustees of high value trusts falling within Article 49(2)(a) to (d) of the Order, and (iii) other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). If you are not a Relevant Person, you should not act upon, or rely on, this announcement. Neither this announcement nor any copy of it may be made or transmitted into the United States, or distributed, directly or indirectly, in the United States. Neither this announcement nor any copy of it may be taken or transmitted directly or indirectly into Australia, Canada, Japan, Hong Kong, India, Singapore, South Africa, the United Arab Emirates or the Kingdom of Saudi Arabia or to any persons in any of those jurisdictions, except in compliance with applicable securities laws. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese, Hong Kong, Indian, Singaporean, South African, United Arab Emirates' or Saudi Arabian securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

The securities to which this announcement relates have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or with any regulatory authority or under any applicable securities laws of any state or other jurisdiction of the United States, and may not be offered or sold within the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with applicable state law. There will be no public offer of the securities in the United States.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STATJBRTMBTBBLP

Top of Page